Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation | |
Shi, Zhengzheng; Zhou, Qing; Gao, Shuhong; Li, Wenzhi; Li, Xin; Liu, Zhiming; Jin, Pengpeng; Jiang, Jie | |
刊名 | LIFE SCIENCES |
2019 | |
卷号 | 217 |
关键词 | Silibinin Endometrial carcinoma STAT3 SREBP1 Proliferation Apoptosis Lipid metabolism |
ISSN号 | 0024-3205 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3598039 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Shi, Zhengzheng,Zhou, Qing,Gao, Shuhong,et al. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation[J]. LIFE SCIENCES,2019,217. |
APA | Shi, Zhengzheng.,Zhou, Qing.,Gao, Shuhong.,Li, Wenzhi.,Li, Xin.,...&Jiang, Jie.(2019).Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.LIFE SCIENCES,217. |
MLA | Shi, Zhengzheng,et al."Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation".LIFE SCIENCES 217(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论